Form 4: Oscar Health EVP Alessandrea Quane Reports Stock Transactions
SEC Form 4
Alessandrea Quane, EVP and Chief Insurance Officer at Oscar Health, reports multiple transactions involving Class A Common Stock, including acquisitions through restricted stock unit vesting and sales to cover tax obligations.
Summary
- Alessandrea C. Quane, EVP and Chief Insurance Officer of Oscar Health, Inc. reported transactions involving Class A Common Stock.
- On June 1, 2024, Quane acquired shares through the vesting of restricted stock units: 7,016 shares, 34,379 shares, and 8,652 shares.
- On June 3 and 4, 2024, Quane sold 25,550 and 668 shares respectively at weighted average prices of $19.46 and $19.09.
- These sales were executed under a Rule 10b5-1 plan to cover tax obligations related to the vesting of equity awards.
- Following these transactions, Quane directly owns 236,679 shares of Class A Common Stock and indirectly owns 76,857 shares through a 2024 GRAT.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the transactions appear to be routine and related to vesting schedules and tax obligations. There is no indication of unusual or concerning activity.
Industry Context
This Form 4 filing is a routine disclosure required by the SEC for corporate insiders, providing transparency into their trading activities. It allows investors to monitor the actions of key personnel and their sentiment towards the company's stock.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the small volume of shares sold by the EVP.
- Employees holding similar equity awards may be interested in the vesting schedules and tax implications.
Key Dates
| Date | Description |
|---|---|
| February 27, 2023 | Date prior to which the Rule 10b5-1 instruction letter was entered into. |
| December 1, 2021 | Start date for vesting of some restricted stock units over a four-year period in 16 equal quarterly installments. |
| June 1, 2023 | Start date for vesting of some restricted stock units over a four-year period in 16 equal quarterly installments. |
| June 1, 2024 | Date of restricted stock unit vesting and acquisition of shares. |
| June 1, 2024 | Start date for vesting of some restricted stock units over a three-year period in 12 equal quarterly installments. |
| June 3, 2024 | Date of sale of 25,550 shares of Class A Common Stock. |
| June 4, 2024 | Date of sale of 668 shares of Class A Common Stock. |
| June 4, 2024 | Date of signature of the report. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.